1. Delfi Diagnostics Appoints Jacob Van Naarden to its Board of Directors

    Delfi Diagnostics Appoints Jacob Van Naarden to its Board of Directors

    Delfi Diagnostics, a pioneering developer of a new class of high-performance, affordable liquid biopsy tests for early cancer detection and monitoring, appointed Jacob Van Naarden, Senior Vice President of Eli Lilly and Company and CEO of Loxo@Lilly, to its board of directors...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      Board Recruitment Publication, BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, Competitor Corner, In the News, Member Report, Partner Publications, Question of The Week, Sponsored Content
  2. Topics Mentioned